South Sudan COVAX vaccine roll-out news
Landmark Event!
— WHO South Sudan (@WHOSouthSudan) March 25, 2021
132K doses of the #AstraZeneca #COVID19 vaccine via #COVAX have just arrived in South Sudan. This is a giant step towards ensuring equitable distribution of COVID-19 vaccines worldwide. #VaccinEquity @unicefssudan @gavi @CEPIvaccines ➡️https://t.co/os7bGZp5U8 pic.twitter.com/HQLqkg9Dsk
24 March 2021
PRESS RELEASE
South Sudan receives first batch of COVID-19 vaccines through the COVAX Facility
“Today is a historic day for South Sudan and its fight against COVID-19,” said Patience Musanhu, Gavi Senior Country Manager for South Sudan. “This delivery is the product of an unprecedented global partnership to ensure every country has access to COVID-19 vaccines. These vaccines are safe, they are effective, and they will be an important tool in the fight against this disease.”
*SII-AstraZeneca (COVISHIELD) vaccine, licensed and manufactured by Serum Institute of India
Track COVAX deliveries on the UNICEF COVID-19 Vaccine Market Dashboard
The central public resource for the latest information on the world’s COVID-19 vaccine market and the COVAX Facility’s vaccine deliveries.